
Big Pharma ad spending edges toward $7B with Sanofi, Regeneron and Novo Nordisk leading the way
Drugmakers spent close to $7 billion on consumer advertising in 2021. The exact final US media tally – $6.88 billion – is up just slightly from the $6.86 billion spent in 2020, according to Kantar’s media tracking data.
Topping the list of drug spending brands is a new leader for the first time in years. Sanofi and Regeneron’s multi-indication asthma and eczema med Dupixent took the top spot from AbbVie’s perennial big spender brand Humira which has been No. 1 since 2015. AbbVie, facing Humira generic competition next year, has taken its foot off the gas and redistributed spending to other brands including Skyrizi and Rinvoq.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.